Christopher Capelli
Founder at SOLITON, INC.
Christopher Capelli active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SOLITON, INC. | Director/Board Member | 2021-01-31 | - |
| Founder | 2021-01-31 | - | |
| Corporate Officer/Principal | 2021-01-31 | - | |
| AUTONOMIX MEDICAL, INC. | Director/Board Member | 2023-08-31 | - |
| Independent Dir/Board Member | 2023-08-31 | - |
Career history of Christopher Capelli
Former positions of Christopher Capelli
| Companies | Position | Start | End |
|---|---|---|---|
| The University of Texas at Austin | Corporate Officer/Principal | 2005-02-28 | 2014-07-31 |
| University of Pittsburgh | Corporate Officer/Principal | 2001-02-28 | 2005-01-31 |
| Biointerface Technologies, Inc. | Founder | 1986-12-31 | 1997-12-31 |
| President | 1986-12-31 | 1997-12-31 |
Training of Christopher Capelli
| Massachusetts Institute of Technology | Undergraduate Degree |
| University of Wisconsin School of Medicine & Public Health | Doctorate Degree |
Statistics
International
| United States | 8 |
Operational
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Founder | 2 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| AUTONOMIX MEDICAL, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Soliton, Inc. (Texas)
 Soliton, Inc. (Texas) Medical SpecialtiesHealth Technology Soliton, Inc. is a medical development company, which engages in the development of healthcare technological devices for medical and cosmetic treatments. Its technology platform include Rapid Acoustic Pulse, a device uses rapid pulses of designed acoustic shockwaves to disrupt cellular structures in the dermal and subdermal tissue. The firm is also in the pre-revenue stage with its first products being developed for the removal of tattoos and the reduction of cellulite. The company was founded by Walter V. Klemp and Christopher Capelli on March 27, 2012 and is headquartered in Houston, TX. | Health Technology |
| Biointerface Technologies, Inc. |
- Stock Market
- Insiders
- Christopher Capelli
- Experience